Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: Evolution over the past 2 decades
Open Access
- 1 January 1991
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 21 (1) , 58-81
- https://doi.org/10.1016/s0001-2998(05)80079-0
Abstract
No abstract availableKeywords
This publication has 157 references indexed in Scilit:
- Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's diseaseMovement Disorders, 1990
- Localization of epileptic foci with postictal single photon emission computed tomographyAnnals of Neurology, 1989
- Initial Experience with SPECT Imaging of the Brain Using 1-123 p-lodoamphetamine in Focal EpilepsyClinical Nuclear Medicine, 1989
- Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsyAnnals of Neurology, 1989
- SPECT Measurements with 99mTc-HM-PAO in Focal EpilepsyJournal of Cerebral Blood Flow & Metabolism, 1988
- STEELE-RICHARDSON-OLSZEWSKI SYNDROMEBrain, 1988
- Studies in Persons at Risk for Huntington's DiseaseNew England Journal of Medicine, 1987
- Tomographic studies of rCBF with99mTc-HM-PAO SPECT in comparison with PET in patients with primary brain tumorsNeurosurgical Review, 1987
- Reduced Cerebral Glucose Metabolism in Asymptomatic Subjects at Risk for Huntington's DiseaseNew England Journal of Medicine, 1987
- Two dopamine receptors: Biochemistry, physiology and pharmacologyLife Sciences, 1984